 |
1 Product |  |
0 Diseases | | 1 Product |
|
1 Trial |  |
138 News |  |
| «12 |
- ||| Erisa (epoetin alfa biosimilar) / PanGen Biotech, CCM Pharma
Clinical: 2/ OTH, there have been several court cases claiming #PBMs are more than “service providers” and exercise discretion in the design of drug benefit plans and therefore should be legally held accountable as a fiduciaries under ERISA. Courts decisions have been muddy. (Twitter) - Jan 3, 2020
- || Erisa (epoetin alfa biosimilar) / PanGen Biotech, CCM Pharma
1/ Per DOL, if a plan sponsor exercises discretion in design and management of health benefit plan — including setting payroll deductions and choice of service providers like #PBMs, they are legally considered fiduciaries under ERISA. https://t.co/VAPIW7Bel9 (Twitter) - Jan 3, 2020
- | Erisa (epoetin alfa biosimilar) / PanGen Biotech, CCM Pharma
Clinical, Journal: Cluster analysis describes constellations of cardiac anomalies presenting in spinal anomaly patients. (Pubmed Central) - Sep 16, 2019
Top congenital cardiac anomalies in vertebral anomaly patients were ASD, PDA, and VSD. VACTERL patients with vertebral anomalies commonly presented alongside cardiac and renal anomalies.
- | Erisa (epoetin alfa biosimilar) / PanGen Biotech, CCM Pharma
The current law only covers non-ERISA plans. (Twitter) - Jul 16, 2019
- | Erisa (epoetin alfa biosimilar) / PanGen Biotech, CCM Pharma
Sorry, fully-insured. I believe these state laws only apply to non-ERISA plans, or something like 20% of the commercial market. (Twitter) - Jul 16, 2019
- | Erisa (epoetin alfa biosimilar) / PanGen Biotech, CCM Pharma
@AmerMedicalAssn On the issue of #SurpriseBills we part company on the matter of #AllPayerDatabases which tend not to reflect #ERISA plan payments - usually the best payments of all. Backing these APDB's is unhelpful. (Twitter) - Jun 17, 2019
- ||| Erisa (epoetin alfa biosimilar) / PanGen Biotech, CCM Pharma
Clinical, Corporate lawsuit, Reimbursement: Err, appellee -> appellant. any other concrete #patientadvocate ideas? Open to collaborating with people to bug legislators. We also need to fix #ERISA plans - they lock people out of lawsuits which removes insurance bad faith judgments. That's a federal issue, tougher to crack (Twitter) - Jun 2, 2019
- || Erisa (epoetin alfa biosimilar) / PanGen Biotech, CCM Pharma
Reimbursement: Yeah insurance Incs are indemnified from med mal by ERISA and HMO Law and from monopolization and collusion by McCarran Ferguson Act https://t.co/BieBuED1FF (Twitter) - Apr 22, 2019